Get started
Author

Dianpeng Zheng

Observed name: Zheng Dianpeng
ORCID: 0000-0002-3141-4885
Observed ORCID: 0000-0002-3141-4885
OpenAlex ID: A5102265689
GLP-1 treatment protects endothelial cells from oxidative stress-induced autophagy and endothelial dysfunction
2018 · Xiangsheng Cai, Miaoqin She, et al. · International Journal of Biological Sciences · 103
PDF
Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells
2016 · Sansan Chen, Xinglu Chen, et al. · Oncotarget · 70
PDF
Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer
2017 · Lijun Mo, Qianmei Chen, et al. · Vaccine · 52
Norcantharidin enhances antitumor immunity of GM ‐ CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells
2018 · Lijun Mo, Xinji Zhang, et al. · Cancer Science · 35
PDF
Cell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer Cells
2016 · Yue He, Daoyu Yan, et al. · PLoS ONE · 29
PDF
Cancer Cell enters reversible quiescence through Intracellular Acidification to resist Paclitaxel Cytotoxicity
2020 · Min Jia, Dianpeng Zheng, et al. · International Journal of Medical Sciences · 11
PDF
Daughter cell fate choice instructed preemptively by mother cells facing nutrient limitation
2023 · Dianpeng Zheng, Yaowen Mao, et al. · iScience · 8
PDF
Pre-RC Protein MCM7 depletion promotes mitotic exit by Inhibiting CDK1 activity
2017 · Dianpeng Zheng, Sichao Ye, et al. · Scientific Reports · 8
PDF
Extended role of p21 during the exit from p21-induced G0/G1 arrest
2024 · Dianpeng Zheng, Zhipeng Ai, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PFKFB3 inhibition dictates the adaptive responses and cell fates in tumor cells
2026 · Dianpeng Zheng, Yaowen Mao, et al. · iScience
【結語】脱は,タキソール誘発性umuc-3ヒト膀胱癌細胞の有糸分裂を阻害する。【jst・京大機械翻訳】
2016 · He Yue, Yan Daoyu, et al.
Works count: 11
Citation count: 315
H-index: 8
I10-index: 6
Year
Topic
Type